Dynamic Technology Lab Private Ltd Makes New Investment in Chemed Corporation $CHE

Key Points

• Dynamic Technology Lab Private Ltd made a new investment of approximately $891,000 in Chemed Corporation, acquiring 1,448 shares in the first quarter.
• Chemed reported a quarterly EPS of $4.27, falling short of the consensus estimate of $6.02, with a revenue of $618.80 million, below expectations of $650.60 million.
• The company recently increased its quarterly dividend to $0.60, reflecting a positive change from the previous $0.50 dividend, with a current yield of 0.5% and a payout ratio of 12.34%.

Dynamic Technology Lab Private Ltd acquired a new position in shares of Chemed Corporation (NYSE:CHE - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 1,448 shares of the company's stock, valued at approximately $891,000.

Other hedge funds have also recently bought and sold shares of the company. Bessemer Group Inc. boosted its holdings in Chemed by 14.2% during the 1st quarter. Bessemer Group Inc. now owns 950 shares of the company's stock worth $585,000 after acquiring an additional 118 shares during the last quarter. DAVENPORT & Co LLC bought a new stake in shares of Chemed during the 1st quarter worth $265,000. Jump Financial LLC bought a new stake in shares of Chemed during the 1st quarter worth $2,777,000. Mather Group LLC. raised its stake in shares of Chemed by 53.3% during the 1st quarter. Mather Group LLC. now owns 161 shares of the company's stock worth $99,000 after purchasing an additional 56 shares during the period. Finally, Park Place Capital Corp raised its stake in shares of Chemed by 71.2% during the 1st quarter. Park Place Capital Corp now owns 3,572 shares of the company's stock worth $2,198,000 after purchasing an additional 1,486 shares during the period. 95.85% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Chemed

In other Chemed news, Director George J. Walsh III acquired 200 shares of the business's stock in a transaction dated Monday, August 4th. The stock was bought at an average price of $417.10 per share, with a total value of $83,420.00. Following the completion of the acquisition, the director owned 3,523 shares of the company's stock, valued at $1,469,443.30. This trade represents a 6.02% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Nicholas Michael Westfall sold 10,012 shares of the business's stock in a transaction dated Monday, August 4th. The stock was sold at an average price of $421.91, for a total value of $4,224,162.92. The disclosure for this sale can be found here. 3.29% of the stock is owned by insiders.

Chemed Price Performance

Shares of CHE traded down $11.89 during midday trading on Friday, hitting $446.00. 160,245 shares of the company traded hands, compared to its average volume of 167,896. The stock has a 50-day moving average of $451.83 and a 200-day moving average of $531.04. Chemed Corporation has a one year low of $408.42 and a one year high of $623.60. The firm has a market cap of $6.50 billion, a P/E ratio of 22.93, a PEG ratio of 2.66 and a beta of 0.46.

Chemed (NYSE:CHE - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The company reported $4.27 earnings per share for the quarter, missing the consensus estimate of $6.02 by ($1.75). Chemed had a net margin of 11.56% and a return on equity of 25.83%. The company had revenue of $618.80 million for the quarter, compared to the consensus estimate of $650.60 million. During the same quarter in the prior year, the company earned $5.47 earnings per share. The company's quarterly revenue was up 3.8% on a year-over-year basis. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. Sell-side analysts forecast that Chemed Corporation will post 21.43 EPS for the current fiscal year.

Chemed Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Monday, August 11th were issued a dividend of $0.60 per share. The ex-dividend date of this dividend was Monday, August 11th. This is a positive change from Chemed's previous quarterly dividend of $0.50. This represents a $2.40 annualized dividend and a dividend yield of 0.5%. Chemed's payout ratio is presently 12.34%.

Analysts Set New Price Targets

A number of research firms have recently commented on CHE. Bank of America lowered their target price on Chemed from $610.00 to $595.00 and set a "buy" rating on the stock in a research note on Wednesday. Royal Bank Of Canada lowered their target price on Chemed from $640.00 to $589.00 and set an "outperform" rating on the stock in a research note on Thursday, July 31st. Oppenheimer lowered their target price on Chemed from $650.00 to $580.00 and set an "outperform" rating on the stock in a research note on Thursday, July 31st. Jefferies Financial Group upgraded Chemed from a "hold" rating to a "buy" rating and lifted their target price for the stock from $490.00 to $550.00 in a research note on Tuesday, September 2nd. Finally, Wall Street Zen cut Chemed from a "buy" rating to a "hold" rating in a research note on Saturday, July 5th. Four analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus price target of $578.50.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.